ADAR1 Capital Management »

Endeavor Group Hldgs shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Endeavor Group Hldgs (EDR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Endeavor Group Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Endeavor Group Hldgs held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Endeavor Group Hldgs by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.5M 123k 28.56
2024-06-30 $287k 11k 27.03
2024-03-31 $4.0M 155k 25.73
2023-12-31 $59k 2.5k 23.73

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Endeavor Group Hldgs

Silver Lake Group
Canada Pension Plan Investment Board
Millennium Management
Pentwater Capital Management
Vanguard Group
Troluce Capital Advisors
MIC Capital Management UK
Athos Capital
Qube Research & Technologies
Balyasny Asset Management
Westchester Capital Management
TIG Advisors
LMR Partners
CNH Partners
BlackRock

View all funds holding Endeavor Group Hldgs